5441842026-04-012026-06-305441842026-06-305441842026-04-012026-06-30in-capmkt:OtherExpenses1Member5441842026-04-012026-06-30in-capmkt:ReportableSegments1Member5441842026-04-012026-06-30in-capmkt:ReportableSegments2Member5441842026-04-012026-06-30in-capmkt:ReportableSegments3Member5441842026-04-012026-06-30in-capmkt:ReportableSegments1Member5441842026-04-012026-06-30in-capmkt:ReportableSegments2Member5441842026-04-012026-06-30in-capmkt:ReportableSegments3Member5441842026-04-012026-06-30in-capmkt:ReportableSegments1Member5441842026-06-30in-capmkt:ReportableSegments1Member5441842026-04-012026-06-30in-capmkt:ReportableSegments2Member5441842026-06-30in-capmkt:ReportableSegments2Member5441842026-04-012026-06-30in-capmkt:ReportableSegments3Member5441842026-06-30in-capmkt:ReportableSegments3Member5441842026-04-012026-06-30in-capmkt:ReportableSegments1Member5441842026-06-30in-capmkt:ReportableSegments1Member5441842026-04-012026-06-30in-capmkt:ReportableSegments2Member5441842026-06-30in-capmkt:ReportableSegments2Member5441842026-04-012026-06-30in-capmkt:ReportableSegments3Member5441842026-06-30in-capmkt:ReportableSegments3Member5441842026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares544184BOROSCINOTLISTEDINE02L001032BOROSIL SCIENTIFIC LIMITEDMain BoardEquity2026-04-012027-03-312026-08-032026-07-27INRLakhsQuarterlyFirst quarterMulti segment2026-08-0315:10:002026-08-0316:15:00Not applicable2026-04-012026-06-30UnauditedConsolidated10675230002666400010941870004100590004493000-8136200021977300025470004887300042999700010343800005980700005980700017548000-129200016256000043551000000043551000-5220004302900043708000-15700043185000-1560008894700010.490.49000.490.49Notes on Unaudited Consolidated Financial Results for the quarter ended 30th June, 2026: <br /> <br /> 1. The above results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held o¬n 3rd August, 2026. The Statutory Auditors of the Company have carried out a Limited Review of the above results. <br /> <br /> 2. Exceptional items comprise: i) Rs. 661.31 lakhs for the quarter ended 30th June, 2025 and the year ended 31st March, 2026, representing expenditure incurred towards the Voluntary Retirement Scheme (VRS) for eligible workers at the Company's plant located at Village Ambad, Nashik, Maharashtra and ii) Rs. 191.51 lakhs for the year ended 31st March, 2026, representing the one-time incremental impact arising from the implementation of the new Labour Codes. <br /> <br /> 3. The figures for the corresponding previous period/year have been rearranged/ regrouped, wherever necessary, to make them comparable. The figures for the quarter ended 31st March, 2026 is the balancing figures between the audited figures of the full financial year and the published year to date figures upto the third quarter of the respective <br /> financial year. <br /> <br /> <br /> For Borosil Scientific Limited <br /> <br /> <br /> <br /> <br /> Place: Mumbai Vinayak Patankar <br /> Date : 3rd August, 2026 Whole-time Director & CEO <br /> (DIN 07534225) <br /> <br /> Other Expenses429997000Scientific – Laboratory Glass & equipment and Process System666811000Glassware383621000Others17091000106752300001067523000Scientific – Laboratory Glass & equipment and Process System93554000Glassware1900000Others42970009975100025470003739700059807000Scientific – Laboratory Glass & equipment and Process System1981095000Glassware1276458000Others33664000329121700022113910005502608000Scientific – Laboratory Glass & equipment and Process System605806000Glassware228142000Others82250008421730001990440001041217000As per Indian Accounting Standard 108 on ‘Operating Segment’ (Ind-AS 108), the Group has reported "Segment information", as described below: <br /> <br /> Scientific – Laboratory Glass & equipment and Process System:- Comprising of items used in laboratories, production floor and research and development <br /> <br /> Glassware:- pharmaceutical primary packaging and domestic glassware items <br /> <br /> Others :- Comprising of Filter Paper etc. <br /> <br /> Unallocated:- Consists of income, expenses, assets and liabilities which can not be directly identified to any of the above segments.Re-measurement gains / (losses) on defined benefit plans-698000-698000-1760000-522000